Nevia Bio is a diagnostics company, developing early detection tests for gynecologic cancers by analyzing vaginal fluid.
Unlike blood-based tests, vaginal fluid is in close proximity to the tumor site and carry stronger signals at earlier stages of the disease. We use AI and a multi-omics approach to detect and monitor these biomarkers and to guide more effective treatments, leading to significantly better outcomes for patients.
Our tests are non-invasive and are designed for patient self-collection, eliminating the need for unnecessary blood drawings, clinical visits, or invasive procedures.
We are redefining what's possible in cancer care for women, starting with ovarian cancer and expanding to a broad range of gynecologic malignancies.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Haifa, Il
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://nevia.bio
- Keywords
- in cancer research.
- HQ
- Haifa
Nevia Bio Questions
Nevia Bio's website is http://nevia.bio
Nevia Bio's LinkedIn profile is https://il.linkedin.com/company/nevia-bio
Nevia Bio has
15 employees.
View email and phone details for 15
employees at Nevia Bio.
Nevia Bio's industry is
Biotechnology Research
Nevia Bio's top competitors are
Pangea Biomed,
Vertos Medical,
Cytoreason,
Guardoc Health,
Foresee Genomics Ltd,
Memed,
Quanthealth,
Curesponse,
Scala Biodesign,
Mindup - The Digital Health Incubator.
Nevia Bio's categories are Biotechnology Research
Nevia Bio's founding year is 2020
